Expanding the Allelic spectrum in ATP1A3-related disorders with 3 novel mutations and clinic features

References

1. 1.
   1. Schirinzi T,
   2. Graziola F,
   3. Cusmai R,
   4. Fusco L,
   5. Nicita F,
   6. Elia M, et al.

   ATP1A3-related epileptic encephalopathy responding to ketogenic diet. Brain Dev 2018; 40: 433–438.

   OpenUrl
2. 2.
   1. Schirinzi T,
   2. Graziola F,
   3. Nicita F,
   4. Travaglini L,
   5. Stregapede F,
   6. Valeriani M, et al.

   Childhood Rapid-Onset Ataxia: Expanding the Phenotypic Spectrum of ATP1A3 Mutations. Cerebellum 2018; 17: 489–493.

   OpenUrl
3. 3.
   1. Capuano A,
   2. Garone G,
   3. Tiralongo G,
   4. Graziola F.

   Alternating Hemiplegia of Childhood: Understanding the Genotype–Phenotype Relationship of ATP1A3 Variations. Appl Clin Genet 2020 13:, 71–81.

   OpenUrlCrossRefPubMed
4. 4.
   1. Sabouraud P,
   2. Riquet A,
   3. Spitz MA,
   4. Deiva K,
   5. Nevsimalova S, et al.

   Relapsing encephalopathy with cerebellar ataxia are caused by variants involving p.Arg756 in ATP1A3. Eur J Paediatr Neurol 2019; 23: 448–455.

   OpenUrlCrossRef
5. 5.
   1. Salles P,
   2. Mata I,
   3. Brünger T,
   4. Lal D,
   5. Fernandez H.

   ATP1A3-Related Disorders: An Ever-Expanding Clinical Spectrum. Front Neurol 2021; 12: 637890.

   OpenUrl
6. 6.
   1. Zou S,
   2. Lan YL,
   3. Gong Y,
   4. Chen Z,
   5. Xu C.

   The role of ATP1A3 gene in epilepsy: We need to know more. Front Cell Neurosci 2023; 17: 1143956.

   OpenUrl